Capsid of HIV-1 behaves like cell’s cargo receptor to enter the nucleus
Biologists demonstrate that HIV-1 capsid acts like a Trojan horse to pass viral cargo across the nuclear pore.
Biologists demonstrate that HIV-1 capsid acts like a Trojan horse to pass viral cargo across the nuclear pore.
The advance makes it easier to detect circulating tumor DNA in blood samples, which could enable earlier cancer diagnosis and help guide treatment.
International energy company becomes sustaining member of industry group.
Cancer nanomedicine was on display at the 2023 White House Demo Day.
MIT researchers find that in mice and human cell cultures, lipid nanoparticles can deliver a potential therapy for inflammation in the brain, a prominent symptom in Alzheimer’s.
MIT professor combines nanoscience and viruses to develop solutions in energy, environment, and medicine.
Human volunteers will soon begin receiving an HIV vaccine that contains an adjuvant developed in Irvine’s lab, which helps to boost B cell responses to the vaccine.
The one-step fabrication process rapidly produces miniature chemical reactors that could be used to detect diseases or analyze substances.
The advance opens a path to next-generation devices with unique optical and electronic properties.
Core-shell structures made of hydrogel could enable more efficient uptake in the body.
The Nano Summit highlights nanoscale research across multiple disciplines at MIT.
The work demonstrates control over key properties leading to better performance.
The LIRAS technique could speed up the development of acoustic lenses, impact-resistant films, and other futuristic materials.
Thin flakes of graphite can be tuned to exhibit three important properties.
MIT CSAIL researchers combine AI and electron microscopy to expedite detailed brain network mapping, aiming to enhance connectomics research and clinical pathology.